Veterinary Medicines

CEVAC IBIRD LYOPHILISATE FOR SUSPENSION FOR CHICKENS

Authorised
  • Avian infectious bronchitis virus, type 793/B, strain 1/96, Live
Download as PDF

Product identification

Medicine name:
CEVAC IBird liofilizzato per sospensione per polli
CEVAC IBIRD LYOPHILISATE FOR SUSPENSION FOR CHICKENS
Active substance:
  • Avian infectious bronchitis virus, type 793/B, strain 1/96, Live
Target species:
  • Chicken (broiler)
  • Chicken (layer hen)
  • Chicken (for reproduction)
Route of administration:
  • Oculonasal use
  • Oral use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type 793/B, strain 1/96, Live
    2.80
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken (broiler)
      • All relevant tissues
        0
        day
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
  • Oral use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • Cardboard box of 1 bottle of 1000 doses
  • Cardboard box of 1 bottle of 2500 doses
  • Cardboard box of 1 bottle of 5000 doses
  • Cardboard box of 1 bottle of 10000 doses
  • Cardboard box of 10 bottles of 500 doses
  • Cardboard box of 10 bottles of 1000 doses
  • Cardboard box of 10 bottles of 2500 doses
  • Cardboard box of 10 bottles of 5000 doses
  • Cardboard box of 10 bottles of 10000 doses
  • Cardboard box of 20 bottles of 500 doses
  • Cardboard box of 20 bottles of 1000 doses
  • Cardboard box of 20 bottles of 2500 doses
  • Cardboard box of 20 bottles of 5000 doses
  • Cardboard box of 20 bottles of 10000 doses
  • Cardboard box of 1 bottle of 500 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Salute Animale S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Zrt.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104537
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0245/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 14/04/2025
Download
Italian (PDF)
Published on: 14/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."